Study Comparing Best Medical Practice With or Without VNS Therapy in Pharmacoresistant Partial Epilepsy Patients

PHASE4TerminatedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
EpilepsyPartial Epilepsy
Interventions
DEVICE

Vagal Nerve Simulation (VNS) Therapy

VNS Therapy + Best Medical Practice including anti-epileptic drugs

DRUG

Best Medical Practive

Best Medical Practice including anti-Epileptic Drugs

Trial Locations (48)

1070

ULB-Hôpital Erasme, Centre de référence pour le traitement de l'épilepsie réfractaire - Neurologie, Brussels

1306

Spesialsykehuset for Epilepsi, Dep of Neurodiagnostics, Sandvika

9000

UZ Gent, Department of Neurology, 1K12/A, Ghent

10126

Centro Epilessia, Dipartimento di Neuroscienze, Torino

15706

Hospital Clínico de Santiago, Santiago de Compostela

17487

Klinik der Ernst-Moritz-Arndt-Universität, Neurologische Klinik, Greifswald

20142

Ospedale San Paolo, Centro Epilessia, Milan

28034

Hospital Ruber Internacional, Servicio de neurología, Madrid

34295

Hôpital Gui De Chauliac, Service Explorations Neurologiques et Epileptologie, Montpellier

35039

Klinikum der Philips-Universität Marburg, Fachbereich, 20 - Medizin / Klinik Neurologie / Epilepsie Zentrum, Marburg

37044

CHU Tours, Service de neurologie, Tours

38043

CHU Grenoble, Neurology Department, Grenoble

40123

Universita di Bologna, Clinica Neurologica, Bologna

41345

Institute of Neuroscience and Physiology, Clinical Neuroscience and Rehabilitation, Gothenburg

46010

Hospital Clínico Universitario, Servicio de neurología, Valencia

46014

Hospital General de Valencia, Neurology/Neurophisiology, Valencia

46930

Hospital General Basico De La Defensa de Valencia, Servicio de neurología, Valencia

50100

Azienda Ospendaliero-Universitaria, Caressi Dep Neuroscience, Florence

53105

Universitätskliniken Bonn, Klinik für Epileptologie, Bonn

56025

Ospedale F. Lotti, NeuroFisioPatalogia, Pontedera

56126

Universita di Pisa, Clinica Neurologica, Pisa

59037

Hopital Roger Salengro, Service de Neurologie, Lille

60100

Azienda Ospedaliero Universitaria - Ospedali Riuniti Umberto I - Lancisi - Salesi, NeuroPsichiatria Infantile, Ancona

67091

Service d'exploration des épilepsies, Strasbourg

69003

Hôpital Neurologique, Untité d'épileptologie, Lyon

75674

Hôpital Sainte-Anne, Service de Neurochirurgie, Paris

77694

Epilepsiezentrum Kork, Kehl-Kork

89100

"Azienda Ospedaliera Bianchi Melacrino Morelli, Centro Regionale Epilessie", Reggio Calabria

91054

Universitätsklinik Erlangen, Zentrum für Epilepsie ZEE, Erlangen

T1Y6J4

Foothills Hospital, Neurology Department, Calgary

B3H 3A7

QEII Health Sciences Centre, Halifax

H2L 4M1

Hopital Notre Dame, Montreal

H3A 2B4

Montreal Neurological Institute, Clinical Research, Montreal

01465

Sächsisches Epilepsiezentrum Radeberg, Epilepsiezentrum Kleinwachau, Radeberg

09042

Universita degli Studi di Cagliari - Policlinico Monserrato, Clinica Neurologica, Monserrato

00168

Università Cattolica Del Sacro Cuore, Istituto di NeuroChirurgia, Roma

1261, AN

Tergooiziekenhuizen, Dienst Neurologie, Blaricum

7513 R

Medisch Spectrum Twente, Dienst Neurologie, Enschede

8025 BV

Stichting Epilepsie Instituut Nederland, Dienst Neurologie, Heemstede

4901 ZG

Kempenhaeghe, Dienst Neurologie, Oosterhout

3078 HT

Medisch Centrum Rijnmond-Zuid, locatie Clara, Dienst Neurologie, Rotterdam

221 85

Universitetssjukhuset i Lund, Neurologiska kliniken, Lund

901 85

Norrlands Universitetssjukhus, Neurocentrum, Umeå

751 85

Akademiska sjukhuset, Neurocentrum, Uppsala

CB2 2QQ

Addenbrookes Hospital, Dept of Neurosurgery, Cambridge

L97LJ

Walton Centre, Dept of Neurosciences, Clinical Sciences Centre, Fazakerley

SE5 9RS

Kings College Hospital, Dept of Neurosurgery, London

WC1N3B

National Hospital for Neurology and Neurosurgery, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cyberonics, Inc.

INDUSTRY

NCT00522418 - Study Comparing Best Medical Practice With or Without VNS Therapy in Pharmacoresistant Partial Epilepsy Patients | Biotech Hunter | Biotech Hunter